Now effective skincare products are mainly based on gentle formulations and bioactive ingredients as its selling points, it can be seen that the a very critical one, a new concept presented to consumers.

it can be seen that the current market growth rate of effective skincare products and bioactive ingredients in the entire market will reach 40% from 2021 to 2027, then the overall market regulation will reach 200 billion RMB by 2027, So this scale is very large.

What do you think is the efficacy of Chinese skincare products What are the characteristics of development?

Recombinant collagen itself is a type of bioactive material, so as market education increases, our consumers recognize such effective skincare products based on bioactive ingredients, then the penetration rate of the entire market will get higher and higher.

What is the trends in the recombinant collagen market in China?

I think this is the case. From a technical point of view, the gap should be getting smaller and smaller, or we have surpassed the international ones in some fields, such as recombinant collagen. Currently, our country implemented on August 1, 2022 Biomedical industry standards recombinant collagen. At the same time, we are currently drafting international standards. The companies that draft international standards are also domestic companies, It's equivalent to saying that we have been recognized by our international peers, so we think the field of recombinant collagen, we are already at the forefront of the world.

From the perspective of raw materials, we will be at the forefront of the world with more and more raw materials in the future, Even though for some of those basic raw materials, we are still a bit far behind with the international big names. but overall the gap is getting smaller and smaller, and this progress is huge.

What do you think is the current gap between Chinese cosmetic ingredients and international raw materials?

Our giant biotechnology has experienced 22 years of development in the field of recombinant collagen. In the past 22 years, we have built a synthetic biology technology platform that is difficult to replicate.Under this technology platform, there are four major technical systems, including Gene recombination, cell factory construction, fermentation, isolation and purification, So we have technological advantages that are leading and unique in every step. When all these factors combined, it's very hard for our competitor to duplicate the whole process. and we have 33 types of recombinant collagen which builds a huge molecularr library. so we are far ahead of our competitors in terms of quantity and variety, This has made the leading position in this industry of all time, so this allows us to always be in a relatively leading positionin this industry.

We have learned that Giant Biotech is the leader in the recombinant collagen market in China, and what methods does Giant Biotech take to maintain What about continuing to lead?

First of all, one of the prerequisites for the release of this application is the release of recombinant collagen industry standard. Under such standard, we have formulated this recombinant collagen quality standard and standardized testing method, So the release of this application is a consensu from the experienced personel from the industry, and they have developed a standardized methods to bring new technologies and new ideas, So overall speaking, it will bring legitimate and usefull information for all of our consumers, The information will bring us important references for the future application of recombinant collagen in the field of skincare and professional skin care.

 Giant Biogene has released recombinant collagen for for skin diseases and skin care, but what impact will the application have on the collagen market?

The characteristics of the consumers are their ample knowledge in the expertise and then they become more rational and professional. They are not superstitious about big names, only believe in efficacy, believe in our Chinese people's own scientific and technological findings.

What do you think are the characteristics of current consumers using recombinant collagen?